Relationship Between HbA1c and Complex Regional Pain Syndrome in Stroke Patients With Type 2 Diabetes Mellitus
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To investigate the relationship between glycosylated hemoglobin A (HbA1c) and complex regional pain syndrome (CRPS) in stroke patients with type 2 diabetes mellitus (T2DM).Methods A retrospective chart review was performed of stroke patients from January 2012 to December 2013. We reviewed 331 patients and included 200 in the analysis. We divided them into CRPS and non-CRPS groups and compared them by age, gender, stroke lesion, cause of stroke, duration of T2DM, HbA1c (%), National Institutes of Health Stroke Scale score, affected shoulder flexor muscle strength, Fugl-Meyer Assessment score, motricity index, Functional Independence Measure, Korean version of Modified Barthel Index, blood glucose level on admission day, duration from stroke onset to HbA1c check, and duration from stroke onset to three-phase bone scan for CRPS diagnosis. Thereafter, we classified the patients into five groups by HbA1c level (group 1, 5.0%–5.9%; group 2, 6.0%–6.9%; group 3, 7.0%–7.9%; group 4, 8.0%–8.9%; and group 5, 9.0%–9.9%) and we investigated the difference in CRPS prevalence between the two groups.Results Of the 200 patients, 108 were in the CRPS group and 92 were in the non-CRPS group. There were significant differences in HbA1c (p<0.05) between the two groups but no significant differences in any other factors. Across the five HbA1c groups, there were significant differences in CRPS prevalence (p<0.01); specifically, it increased as HbA1c increased.Conclusion This study suggests that higher HbA1c relates to higher CRPS prevalence and thus that uncontrolled blood glucose can affect CRPS occurrence in stroke patients with diabetes.
Abstract
Objective To investigate the relationship between glycosylated hemoglobin A (HbA1c) and complex regional pain syndrome (CRPS) in stroke patients with type 2 diabetes mellitus (T2DM).Methods A retrospective chart review was performed of stroke patients from January 2012 to December 2013. We reviewed 331 patients and included 200 in the analysis. We divided them into CRPS and non-CRPS groups and compared them by age, gender, stroke lesion, cause of stroke, duration of T2DM, HbA1c (%), National Institutes of Health Stroke Scale score, affected shoulder flexor muscle strength, Fugl-Meyer Assessment score, motricity index, Functional Independence Measure, Korean version of Modified Barthel Index, blood glucose level on admission day, duration from stroke onset to HbA1c check, and duration from stroke onset to three-phase bone scan for CRPS diagnosis. Thereafter, we classified the patients into five groups by HbA1c level (group 1, 5.0%–5.9%; group 2, 6.0%–6.9%; group 3, 7.0%–7.9%; group 4, 8.0%–8.9%; and group 5, 9.0%–9.9%) and we investigated the difference in CRPS prevalence between the two groups.Results Of the 200 patients, 108 were in the CRPS group and 92 were in the non-CRPS group. There were significant differences in HbA1c (p<0.05) between the two groups but no significant differences in any other factors. Across the five HbA1c groups, there were significant differences in CRPS prevalence (p<0.01); specifically, it increased as HbA1c increased.Conclusion This study suggests that higher HbA1c relates to higher CRPS prevalence and thus that uncontrolled blood glucose can affect CRPS occurrence in stroke patients with diabetes.
참고문헌 (37)
- Stanton-Hicks M, "Reflex sympathetic dystrophy:changing concepts and taxonomy", Pain, 63, pp.127~133 (1995)
- Merskey H, "Classification of chronic pain:descriptions of chronic pain syndromes and definitions of pain terms" (1994), IASP Press
- Pertoldi S, "Shoulder-hand syndrome after stroke: a complex regional pain syndrome", Eura Medicophys, 41, pp.283~292 (2005)
- Tepperman PS, "Reflex sympathetic dystrophy in hemiplegia", Arch Phys Med Rehabil, 65, pp.442~447 (1984)
- Cheng PT, "Prediction of reflex sympathetic dystrophy in hemiplegic patients by electromyographic study", Stroke, 26, pp.2277~2280 (1995)
- Daviet JC, "Clinical factors in the prognosis of complex regional pain syndrome type I after stroke: a prospective study", Am J Phys Med Rehabil, 81, pp.34~39 (2002)
- Marinus J, "Clinical features and pathophysiology of complex regional pain syndrome", Lancet Neurol, 10, pp.637~648 (2011)
- Wyatt LH, "The musculoskeletal effects of diabetes mellitus", J Can Chiropr Assoc, 50, pp.43~50 (2006)
- Pickup JC, "Is type II diabetes mellitus a disease of the innate immune system?", Diabetologia, 41, pp.1241~1248 (1998)
- Malkani S, "Implications of using hemoglobin A1C for diagnosing diabetes mellitus", Am J Med, 124, pp.395~401 (2011)
- Graf RJ, "Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects", Ann Intern Med, 94, pp.307~311 (1981)
- Marshall AT, "Reflex sympathetic dystrophy", Rheumatology (Oxford), 39, pp.692~695 (2000)
- Kim RP, "The musculoskeletal complications of diabetes", Curr Diab Rep, 2, pp.49~52 (2002)
- Harden RN, "Proposed new diagnostic criteria for complex regional pain syndrome", Pain Med, 8, pp.326~331 (2007)
- Stanton-Hicks MD, "An updated interdisciplinary clinical pathway for CRPS: report of an expert panel", Pain Pract, 2, pp.1~16 (2002)
- Calder JS, "Evidence for immune system involvement in reflex sympathetic dystrophy", J Hand Surg Br, 23, pp.147~150 (1998)
- van der Laan L, "Reflex sympathetic dystrophy:an exaggerated regional inflammatory response?", Hand Clin, 13, pp.373~385 (1997)
- Holzer P, "Neurogenic vasodilatation and plasma leakage in the skin", Gen Pharmacol, 30, pp.5~11 (1998)
- Birklein F, "The important role of neuropeptides in complex regional pain syndrome", Neurology, 57, pp.2179~2184 (2001)
- Schinkel C, "Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome", Clin J Pain, 22, pp.235~239 (2006)
- Huygen FJ, "Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1", Immunol Lett, 91, pp.147~154 (2004)
- Groeneweg JG, "Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1", BMC Musculoskelet Disord, 7, pp.91~ (2006)
- Uceyler N, "Differential expression patterns of cytokines in complex regional pain syndrome", Pain, 132, pp.195~205 (2007)
- Wesseldijk F, "Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1", Mediators Inflamm, 2008, pp.469439~ (2008)
- Parkitny L, "Inflammation in complex regional pain syndrome: a systematic review and meta-analysis", Neurology, 80, pp.106~117 (2013)
- Pickup JC, "Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes", Diabetes Care, 27, pp.813~823 (2004)
- Crook MA, "Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy", Diabetes Care, 16, pp.57~60 (1993)
- Mirza S, "Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans:a cross-sectional study", Cytokine, 57 (2012)
- Alexandraki KI, "Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation", J Clin Immunol, 28, pp.314~321 (2008)
- Bastard JP, "Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance", Diabetes Metab Res Rev, 16, pp.192~201 (2000)
- Donath MY, "Type 2 diabetes as an inflammatory disease", Nat Rev Immunol, 11, pp.98~107 (2011)
- Pickup JC, "Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes", Life Sci, 67, pp.291~300 (2000)
- Dandona P, "The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes", J Clin Endocrinol Metab, 88, pp.2422~2429 (2003)
- Veldman PH, "Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients", Lancet, 342, pp.1012~1016 (1993)
- Kozin F, "Reflex sympathetic dystrophy syndrome: a review", Clin Exp Rheumatol, 10, pp.401~409 (1992)
- Schwartzman RJ, "Reflex sympathetic dystrophy: a review", Arch Neurol, 44, pp.555~561 (1987)
- Shelton RM, "Reflex sympathetic dystrophy:a review", J Am Acad Dermatol, 22, pp.513~520 (1990)